New MUHC study calls for targeted screening of high-risk healthcare workers for tuberculosis
Tuberculosis (TB) is a recognized hazard for healthcare workers, but the annual screening strategy currently in place in Canada...
Interview with Dr. Isabelle Gagnon
FACE TO FACE with Dr. Isabelle Gagnon, a researcher who goes beyond borders to better understand childhood concussion...
Coming together: A good move for the Centre for Outcomes Research and Evaluation
Over 50 population health researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) and their research teams...
Kidney graft success - does age and sex matter?
The success of kidney transplant is dependent on the age and sex of both the donor and the recipient, according to research published...
Interview with Dr. Isabel Fortier
When I was little, I was fascinated by the way the human body works. Later I decided to study biology to find out more about it, and I went into epidemiology for my doctorate...
A prescription with legs!
A study from the Research Institute of the McGill University Health Centre (RI-MUHC) shows that physician-delivered step count...
What is high Lipoprotein(a), and should I be concerned?
A team of researchers from the Research Institute of the McGill University Health Center (RI-MUHC) found that elevations in a unusual...
A race against time to diagnose deadly weight loss in cancer patients
About one third of cancer patients die because of cachexia – an involuntary weight loss, characterized primarily by muscle wasting and metabolic changes, which cannot be addressed or treated solely...
Inappropriate and overuse of antibiotics in fight against tuberculosis in India
Simulated patient study sheds new light on antibiotic use in India
Critical years ahead in fight against hepatitis C virus
In the last five years, new drugs have revolutionized the treatment of hepatitis C (HCV), a virus that causes serious liver disease.